Close

Systech secures $7.5m finance for software products expansion

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

AI-Driven Small Molecule Therapies for I&I Diseases

AI Advances Small Molecule Therapies for I&I Diseases Driven by...

Biopharma Docs Transformed with Component-Based Approach

Simplifying Biopharma Workflows: How Component-Based Authoring Is Changing Clinical...

AI Revolutionizing Life Sciences Documentation for Intelligent Workflows

Future of Life Sciences Documentation: AI, Automation, and the...

AI Transforms Pharmaceutical Documentation Processes

Transformational Pharmaceutical Documentation: AI-Driven Structured Content for Compliance, Effectiveness,...

Pharma serialization solutions provider Systech International has secured $7.5m as a venture loan from Horizon Technology Finance.

The company will use the finance to expand its comprehensive suite of software products and services.

Horizon president Gerald Michaud said, “We are pleased to provide this venture loan to Systech, a company poised for growth with its comprehensive suite of software products and services for manufacturers in the global pharmaceutical and related industries aimed at meeting stringent regulatory requirements and improving operating efficiencies.”

Systech International president and CEO Robert DeJean said the company is experiencing significant growth and required additional capital to finance its continued expansion.

“The Horizon team carefully considered our needs and structured a financing solution that will support our working capital needs to meet the strategic goals of our company,” DeJean added.

“We appreciate Horizon’s confidence in Systech and welcome them as a value-added financial partner.”

Latest stories

Related stories

AI-Driven Small Molecule Therapies for I&I Diseases

AI Advances Small Molecule Therapies for I&I Diseases Driven by...

Biopharma Docs Transformed with Component-Based Approach

Simplifying Biopharma Workflows: How Component-Based Authoring Is Changing Clinical...

AI Revolutionizing Life Sciences Documentation for Intelligent Workflows

Future of Life Sciences Documentation: AI, Automation, and the...

AI Transforms Pharmaceutical Documentation Processes

Transformational Pharmaceutical Documentation: AI-Driven Structured Content for Compliance, Effectiveness,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back